Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Income Tax Expense Over TimeContracting
Percentile Rank79
3Y CAGR-8.8%
5Y CAGR+11.2%
Year-over-Year Change
Income taxes paid or accrued
3Y CAGR
-8.8%/yr
Annual compound
5Y CAGR
+11.2%/yr
Recent deceleration
Percentile
P79
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $690.00M | -12.0% |
| 2024 | $784.10M | +3.1% |
| 2023 | $760.20M | -16.5% |
| 2022 | $910.40M | +134.5% |
| 2021 | $388.30M | -4.2% |
| 2020 | $405.15M | +85.8% |
| 2019 | $218.11M | +114.7% |
| 2018 | $-1.49B | -1285.4% |
| 2017 | $-107.32M | -744.0% |
| 2016 | $16.66M | - |